South Dakota
Prescription drug spending and prescribing in South Dakota, from Medicare Part D and Medicaid, with the life-science companies raising money there and state attorney general health-care antitrust cases. Compare every state.
In 2024, Medicare Part D plans paid $699M for prescriptions written in South Dakota, the 48th most of 52 states and territories, and 3.5% of its claims were opioids against 3.5% nationally.
- Medicare Part D, 2024: $699M
- Medicaid drugs, 2025: $282M
- Opioid share of claims: 3.5%
- Life-science raises, 2 years: $6M
Opioid Share of Part D Claims, 2024
South Dakota outlined; every state in quartiles. Click a state to compare.
- Up to 3.2%
- 3.2% to 3.7%
- 3.7% to 4.3%
- Over 4.3%
South Dakota Against the Nation
Share of Part D claims; dark is the state, light the US.
- Opioids, South Dakota3.5%
- Opioids, US3.5%
- Antibiotics, South Dakota4.3%
- Antibiotics, US4.4%
- Antipsychotics, South Dakota1.8%
- Antipsychotics, US1.7%
How It Prescribes
Medicare Part D, 2024, by the prescriber's state| Share of Part D claims | South Dakota | United States | Difference |
|---|---|---|---|
| Opioids | 3.5% | 3.5% | -2% |
| Antibiotics | 4.3% | 4.4% | -3% |
| Antipsychotics | 1.8% | 1.7% | +4% |
Most Distinctive Drugs
Prescribed most out of line with the rest of the country: the drug's share of South Dakota's claims against its share nationally| Drug | Against national rate | Claims |
|---|---|---|
| Sodium Chloride/Nahco3/Kcl/Peg | 4.2× | 4,562 |
| Pen Needle,dual Safety,diabetc | 2.8× | 3,065 |
| Warfarin Sodium | 2.7× | 39,237 |
| Calcitriol | 2.5× | 9,703 |
| Clozapine | 2.5× | 8,410 |
| Fentanyl | 2.5× | 5,838 |
| Dofetilide | 2.2× | 2,127 |
| Flecainide Acetate | 2.2× | 8,123 |
| Insulin Aspart (Niacinamide) | 2.2× | 3,044 |
| Digoxin | 2.1× | 9,582 |
Biggest Medicaid Drugs
What South Dakota's Medicaid program paid pharmacies, before rebates; see every drugLife-Science Fundraising
7 Form D raises by companies based in South Dakota in the last two years; the 10 largest. See all raises- Norman Retirement, LLC$4M · Other health care · Sep 10, 2026
- INANOVATE INC$900K · Biotech · Nov 15, 2024
- INANOVATE INC$808K · Biotech · Jul 2, 2025
- Countach Medical Corp$400K · Other health care · Jun 5, 2026
- Prosperous Robotics Group, Inc.$150K · Other health care · Jul 30, 2025
- Immuno Cancer Biotherapeutics, Inc.$75K · Biotech · Oct 15, 2026
- Datavyne, Inc.$55K · Other health care · May 20, 2026
State Attorney General Health-Care Cases
Antitrust cases South Dakota joined, newest first; see every case- New York et al. v. Cephalon, No. 2:16-cv-04234 (E.D. Pa. Aug. 4, 2016)2016 · Settled
- Maryland v. SmithKline Beecham Corp., No. 2:06-cv-01298-JP (E.D.Pa Mar. 27, 2006)2006 · Settled
- Maryland et al. v. Perrigo Company, No. 1:04CV01398 (D.D.C. Aug. 17, 2004)2004 · Settled
- Texas et al. v. Organon (Remeron), No. 04-5126 (D.N.J. 2004)2004 · Settled
- In re Cardizem CD Antitrust Litigation 99-MD-1278 (E.D. Mich. Jan. 29, 2003), 332 F.3d 896 (6th Cir. 2003)2003 · Settled
- Ohio, et al, v. Bristol-Myers Squibb Co., et al.(D.D.C. 2002); see also In re Buspirone Antitrust Litigation,Case No. 01 CV 11401, MDL…2002 · Settled
- Connecticut v. Mylan Laboratories, Inc. (In re Lorazepam & Clorazepate Antitrust Litigation), MDL No. 1290 (D.D.C. June 15, 2000) 205…2000 · Settled
- In re Clozapine Antitrust Litigation, MDL No. 874 (N.D. Ill. 1991)1991 · Settled
- In re DDAVP Antitrust LitigationConsent decree
- In the Matter of GlaxoSmithKline, PLC (Augmentin)Settled
Other States
Alabama · Alaska · Arizona · Arkansas · California · Colorado · Connecticut · Delaware · District of Columbia · Florida · Georgia · Hawaii · Idaho · Illinois · Indiana · Iowa · Kansas · Kentucky · Louisiana · Maine · Maryland · Massachusetts · Michigan · Minnesota · Mississippi · Missouri · Montana · Nebraska · Nevada · New Hampshire · New Jersey · New Mexico · New York · North Carolina · North Dakota · Ohio · Oklahoma · Oregon · Pennsylvania · Puerto Rico · Rhode Island · South Carolina · Tennessee · Texas · Utah · Vermont · Virginia · Washington · West Virginia · Wisconsin · Wyoming
Part D is by the prescriber's state, Medicaid by the paying state program, and Form D by the issuer's stated address. Amounts are before manufacturer rebates. Refreshed weekly. CMS Medicare Part D Prescribers by Geography; CMS State Drug Utilization Data; SEC Form D; NAAG